Intensive chemotherapy for a relapsed ALL patient who received living-donor lobar lung transplantation

Bone Marrow Transplantation

Volumn 47, Issue 1, 2012, Pages 135-136

  Ishiyama, K ^a,b   Okumura, H ^a,c   Yamazaki, H ^a   Kondo, Y ^a   Waseda, Y ^a   Kotani, T ^a   Takami, A ^a   Nakao, S ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BRONCHIOLITIS OBLITERANS; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CONSOLIDATION CHEMOTHERAPY; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; ILEUS; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY DYSFUNCTION; LETTER; LEUKEMIA RELAPSE; LEUKOENCEPHALOPATHY; LIVER DYSFUNCTION; LIVING DONOR; LUNG TRANSPLANTATION; PERFORMANCE STATUS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RASH; SUBILEUS;

ADOLESCENT; FEMALE; HUMANS; INTENSIVE CARE; LIVING DONORS; LUNG TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84855719778     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.5     Document Type: Letter

References (6)

1. Roca J, Granena A, Rodriguez-Roisin R, Alvarez P, Agusti-Vidal A, Rozman C. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax 1982; 37: 77-78. (Pubitemid 12135885)
2. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376. (Pubitemid 19231290)
3. Okumura H, Ohtake S, Ontachi Y, Ozaki J, Shimadoi S, Waseda Y et al. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 2007; 86: 369-373.
4. Sakata-Yanagimoto M, Kanda Y, Nakagawa M, Asano-Mori Y, Kandabashi K, Izutsu K et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1043-1047. (Pubitemid 38744792)
5. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-905. (Pubitemid 28446849)
6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655. (Pubitemid 13149996)